Insights Into Management of Atrial Fibrillation in Asia Pacific Gained From Baseline Data from REgistry on Cardiac rhythm disORDers (RecordAF-Asia Pacific [AP]) Registry

The burden of atrial fibrillation (AF) and the lack of data on AF and its management in the Asia Pacific highlight the need for a comprehensive prospective study of AF management in this region. To address this need, the REgistry on Cardiac rhythm disORDers (RecordAF-Asia Pacific [AP]) has been init...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology Vol. 109; no. 3; pp. 378 - 382
Main Authors: Amerena, John, Chen, Shih-Ann, Sriratanasathavorn, Charn, Cho, Jeong-Gwan, Huang, Dejia, Omar, Razali, Tse, Hung Fat, King, Anthony
Format: Journal Article
Language:English
Published: New York, NY Elsevier Inc 01.02.2012
Elsevier
Elsevier Limited
Subjects:
Aged
Anti-Arrhythmia Agents - therapeutic use
Asia - epidemiology
Atrial Fibrillation - epidemiology
Atrial Fibrillation - physiopathology
Atrial Fibrillation - therapy
Biological and medical sciences
Cardiac arrhythmia
Cardiac dysrhythmias
Cardiac Resynchronization Therapy - methods
Cardiology
Cardiology. Vascular system
Cardiovascular
Cardiovascular disease
Clinical outcomes
Electrocardiography
Female
Follow-Up Studies
Heart
Heart Rate
Humans
Incidence
Male
Medical sciences
Medical treatment
Middle Aged
Prognosis
Prospective Studies
Registries
Survival Rate - trends
Asia
Asia-Pacific region
Clinical management
Arrhythmia
Heart disease
Atrial fibrillation
Cardiovascular disease
Data
Circulatory system
Cardiology
Excitability disorder
Gain
ISSN:0002-9149, 1879-1913, 1879-1913
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The burden of atrial fibrillation (AF) and the lack of data on AF and its management in the Asia Pacific highlight the need for a comprehensive prospective study of AF management in this region. To address this need, the REgistry on Cardiac rhythm disORDers (RecordAF-Asia Pacific [AP]) has been initiated to assess the management of AF in 8 countries across the Asia Pacific. RecordAF-AP is a prospective, observational survey of the management of recently diagnosed AF with 1 year of follow-up. Eligible patients with AF, treated or not, were included in the registry; with data recorded prospectively during the follow-up visits at 6 and 12 months. A total of 2,721 patients with AF were recruited, of whom 2,629 were eligible for evaluation (intent-to-treat population). At study inclusion, rhythm- and rate-control strategies were applied to 37% (n = 959) and 62% (n = 1,610) of the patients, respectively. At baseline, the rhythm-control patients were mainly prescribed class III agents (49%), class Ic agents (39%), or β blockers (except for sotalol; 35%). The rate-control patients were mainly prescribed β blockers (except for sotalol; 57%) or cardiac glycosides (32%). Patients receiving rate-control strategies were more likely to have a history of heart failure or valvular heart disease and persistent AF. In contrast, those receiving rhythm-control strategies were more likely to have recently diagnosed or paroxysmal AF. In conclusion, RecordAF-AP will provide much needed insight into the real-life management of patients with AF in the Asia Pacific region.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:0002-9149
1879-1913
1879-1913
DOI:10.1016/j.amjcard.2011.08.046